New study tests Brain-Focused pain education to ease suffering in breast cancer survivors

NCT ID NCT04730154

Ongoing Symptom relief Sponsor: Universitair Ziekenhuis Brussel Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a type of pain education that teaches the brain's role in pain, combined with motivational interviewing, can reduce chronic pain in breast cancer survivors. 156 women who have finished primary treatment and still have pain will be randomly assigned to this new approach or to standard biomedical education. The goal is to see if the new method reduces pain and improves quality of life over 12 to 24 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pain neuroscience education and motivational interviewing
What this could lead to: If it works, this could offer a non-drug way to reduce chronic pain and opioid use in breast cancer survivors.
What could go wrong: This is a relatively small, early-stage behavioral study. The intervention may not prove superior to standard education, and results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST NEOPLASMS PAIN, CHRONIC SURVIVORSHIP

Contacts and locations

Locations

AZ Rivierenland

Bornem, Antwerpen, 2880, Belgium
Imeldaziekenhuis

Bonheiden, Vlaams-Brabant, 2820, Belgium
Universiteit Hasselt - campus Diepenbeek

Diepenbeek, Limburg, 3590, Belgium
Vrije Universiteit Brussel

Jette, Brussels Capital, 1090, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.